This hypothesis was recently supported by Roux et al., who assessed a homogenous IDH wildtype glioblastoma population (n = 392) and found no difference in localization between glioblastoma with and without MGMT methylation, in line with our study (21). The gene discussed is IDH2; the disease is glioblastoma.